| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |